Furthermore, in a mouse model deficient in the NFE2L3 transcription factor, mast cell activity can be regulated through the upregulation of RAB27A, which enhances IL-33 activity and mediates the transition between inflammation and cancer [120, 121]. Here, IL33 is linked to cancer.